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Psoriatic arthritis (PsA) is an inflammatory arthritis associated with psoriasis. 
Psoriasis is a dermatological condition that affects 1-2% of the population. 
Approximately 10-15% of patients with skin manifestations of psoriasis develop PsA 
[1] and 0.3-1% of the general population [2]. Moll and Wright [3] defined PsA as 
psoriasis associated with inflammatory arthritis and usually a negative serological 
test for rheumatoid factor (RF). 
 
Meaney and Hays [4] in 1957, in one of the earlier studies of this disease, grouped 
the radiographic findings of 15 patients with psoriasis and arthritis into two 
categories. The first group [n=11] consisted of changes typical of rheumatoid 
arthritis (RA), for which the term psoriasis with rheumatoid arthritis was used. The 
second group [n = 4] consisted of findings that were not typical of RA, including 
varying degrees of articular destruction involving the terminal interphalangeal joints 
that may progress to lysis of the joint and eventual fibrous or bony fusion. 
Generalised demineralisation of bone was not a feature of this second group. This 
second group represented a distinct type of arthritis referred to as psoriatic arthritis. 
Currently the concept of PsA is well established. 
 
The aetiology of PsA is thought to be a combination of environmental and genetic 


















The clinical nature of the articular disease is variable. A monoarticular, 
pauciarticular or polyarticular distribution can be encountered. Almost any joint can 
be affected, although the small joints of the hands and feet are most frequently 
involved. The near constant involvement of the fingernails in patients manifesting 
with arthritis of the hands is well recognized [4]. These nail changes include pitting, 
discoloration, ridging, splintering, thickening and detachment [3,6]. In some patients 
lower back pain predominates, related to the involvement of the spine and sacroiliac 
joints. The articular symptoms may be acute or insidious in nature. 
Laboratory analysis confirms the absence of serologically detectable RF in the 
majority of patients. This articular disorder has a wide clinical and radiological 
spectrum.  
 
Five broad clinical varieties of PsA have been described [1,3,6,7]:  
Subgroup 1 (classic psoriasis) includes erosion of the terminal tufts known as acro-
osteolysis and involvement of the distal and occasionally the proximal 
interphalangeal (PIP) joints of the hand. 
Subgroup 2 (arthritis mutilans) is known for the „opera glass‟ deformity of the 
hands. 
Subgroup 3 (symmetric polyarthritis) may result in ankylosis of the proximal & 
distal interphalangeal (DIP) joints and in this form is indistinguishable from RA. 
Subgroup 4 is the most common and is characterized by oligoarthritis, which is 
asymmetric, involving the proximal and distal interphalangeal & 
metacarpophalangeal (MCP) joints accompanied by sausage shaped digits. 
Subgroup 5 is a spondyloarthropathy with features similar to ankylosing spondylitis. 
 
Although radiographic abnormalities accompany each of these five subgroups, 
features in certain groups are much more specific than those in other groups. In some 
patients, a single diagnosis of PsA cannot be accomplished on the basis of 











A large, multicentre international study (CASPAR: Classification criteria for 
psoriatic arthritis) published in 2006 [8], compared the accuracy of existing 
classification criteria for the diagnosis of PsA and constructed new criteria from the 
observed data. The researchers concluded that the CASPAR criteria were more 
specific (98.7% vs 96%), but less sensitive (91.4% vs 97.2%), than those of the 
Vasey and Espinoza classification [9].  
 
The CASPAR criteria consist of established inflammatory articular disease (joint, 
spine or entheseal) with at least 3 points from the following five categories:  
1. Current psoriasis (assigned a score of 2); 
A history of psoriasis (in the absence of current psoriasis - assigned a score of 
1); 
A family history of psoriasis (in the absence of current psoriasis and history 
of psoriasis - assigned a score of 1) 
2. Dactylitis (assigned a score of 1) 
3. A negative test for RF (assigned a score of 1) 
4. Nail dystrophy (assigned a score of 1) 
5. Juxta articular new bone formation (assigned a score of 1) 
Dactylitis is considered a hallmark of PsA occurring in 16-24% of reported cases 



















Radiography is the first imaging study in the evaluation of arthritis. The role of 
radiography in the assessment of patients with RA, where the baseline radiographic 
changes predict progression of structural damage, have led to similar observations of 
predictive validity of baseline structural damage in PsA. Radiographic changes were 
used as an outcome measure in several drug trials and demonstrated superiority of 
some drug regimens over others [11].  
The role of radiography in the assessment of patients with PsA is twofold. Firstly, it 
assists in the assessment of the structural damage caused by PsA and secondly it is 
an important outcome measure to judge the efficacy of treatment [12]. 
 
In the initial phase of PsA, radiographs may be entirely normal. Early radiographic 
abnormalities, which may include soft tissue swelling and some degree of 
osteopaenia, can resolve without any permanent sequelae [1]. Osteopaenia is not a 
prominent feature of PsA [4,13]. This lack of osteopaenia is a reliable sign in the 
differentiation of PsA from RA, although the presence of osteopaenia does not 
eliminate the diagnosis of PsA [12,14]. The lack of both intense synovial 
inflammation and severe synovial hyperaemia in this disease may account for the 
absence of significant periarticular osteopaenia. More extensive radiographic 
abnormalities appear with clinical progression of articular problems. These may 
worsen at a variable rate and may be influenced by impairment of hand function. 
 
The radiographic features of PsA can be grouped into destructive and proliferative 
changes [6,12]. These changes occur simultaneously and in this manner PsA differs 
from RA [12]. Findings may be bilateral or unilateral and symmetric or asymmetric. 
The asymmetric distribution is emphasised as a distinctive feature in PsA. The 
destructive arthritis of the DIP joints of the hands is the best recognised 
manifestation of PsA [15]. In PsA the DIP joints are frequently involved from the 
beginning, while in rheumatoid arthritis DIP involvement is more often a feature of 
late disease [15] and is relatively uncommon. Adjacent PIP joints are frequently 
affected and severe abnormalities may be encountered at the interphalangeal joint 











Erosions are a typical feature of the destructive group. These include erosions of the 
terminal phalangeal tufts (acro-osteolysis) and whittling of phalanges, metacarpals 
and metatarsals. Advanced bone destruction may result in a „pencil in cup‟ 
appearance with one end of the joint forming a „cup‟ and the other a sharp  „pencil‟ 
which projects into this cup. This appearance is not specific for PsA or any of the 
seronegative spondyloarthritides, but it is most commonly seen in these conditions 
[5]. RA rarely causes similar radiological changes [16]. 
 
PsA resembles RA in that the erosions occur in the bare area of the bone [15], the 
region between the cartilage covered joint surface and the joint capsule, frequently 
starting at the joint margins and then progressing towards the centre. In PsA the 
erosions become irregular with disease progression, as a result of periosteal bone 
formation adjacent to the erosions [14,15] and involve the DIP joints in addition to 
the PIP, MCP and wrist joints. The bare area erosions on the distal surface of the DIP 
joints in PsA have a characteristic appearance that suggests „mouse ears‟. The 
erosions may become so extensive, resulting in the appearance of a widened joint, 
rather than a narrowed joint space [6,11]. It is this lack of apposition of adjacent 
bone margins that distinguishes the radiographic picture of PsA from that of 
osteoarthritis [6], in which closely applied undulating osseous surfaces are 
encountered.  
 
In contrast, the erosions of the IPJs in erosive osteoarthritis are secondary to articular 
cartilage destruction. The resultant „gull wing‟ deformity is due to the marked 
peripheral bone erosion involving the distal subchondral cortex and the marked 
central bone erosion involving the proximal side of the joint [15]. The predilection of 
erosive osteoarthritis for scattered DIP and PIP joints may make it impossible to 
distinguish from PsA. Clinically, osteoarthritis may pose a diagnostic dilemma when 
associated with Heberden‟s nodes, as early active nodes may be red and swollen, 
similar to PsA of the DIP joint [3]. It is only later that the single globular swelling of 












Juxta articular bone proliferation, a striking feature of PsA [12], may create a 
spiculated, frayed or „paintbrush‟ appearance. An irregular and indistinct appearance 
of the marginal bone, so called „whiskering‟ (5), is also encountered. Although bone 
proliferation may accompany erosions in gouty arthritis, the resulting excrescences 
in gout are well defined. Intra articular osseous fusion is another manifestation of 
bone proliferation in PsA. It is particularly prominent in the hands and feet. Although 
intra articular osseous fusion is also observed in inflammatory erosive osteoarthritis, 
septic arthritis and RA (carpal and tarsal regions), Resnick and Niwayama [6] have 
stressed it as an important radiographic sign of the seronegative spondyloarthritides. 
Bone proliferation occurs at sites at which tendons and ligaments insert on bones 
(„enthesis‟). These include the posterior and inferior surfaces of the calcaneus, the 
femoral trochanters, ischial tuberosities, medial and lateral malleoli, the ulnar 
olecranon, the anterior surface of the patella and the condyles of the distal femur and 
proximal tibia. The simultaneous processes of osteolysis and total ankylosis may 
occur.  
 
Periostitis in the metaphyses and diaphyses of bones is not uncommon, particularly 
in the hands and feet [12]. This change may appear early in the disease, associated 
with soft tissue swelling, before significant abnormalities occur in the adjacent 
articulations. A similar abnormality accompanies reactive arthritis, juvenile chronic 
arthritis and infection. The periostitis has several forms, appearing as a thin 
periosteal layer of new bone adjacent to the cortex, a thick irregular layer or an 
irregular thickening of the cortex. It may be difficult to define where periostitis ends 
and bone erosion begins, as both may produce marked irregularity of the osseous 
surface. The periostitis may occur in areas without bone erosions, such as the radial 
aspect of the wrist extending into the first metacarpal bone. In summary, severe 
marginal and central erosions, bone ankylosis, the absence of osteopaenia as well as 
fraying and irregularity of the periarticular surfaces, differentiate PsA from RA. 
Condensation of bone on the periosteal and endosteal surfaces of the cortex and 
trabecular thickening in the spongiosa can cause an entire phalynx to appear 











in the foot classically involving the distal phalanges, particularly the first, with 
sclerosis, enthesitis and soft tissue swelling.  
Reports in the literature reveal significant variability [17,18] regarding the 
prevalence of sacroiliitis in patients with PsA. This inconsistency is multifactorial, 
including a wide spectrum of disease intensity and difficulty in achieving consensus 
amongst clinicians regarding standardised classification patterns. Sacroiliac joint 
involvement in PsA is usually bilateral, either symmetric or asymmetric in 
distribution, but can also be unilateral [17]. Symmetrical abnormalities predominate. 
These changes occur predominantly in the ilium. The 5- point grading scale, 
according to the Atlas of Standard Radiographs in Arthritis [19], follows the 
recommendations of the New York Conference for Population Studies. The scores 
ranged from 0 to 4: grade 0 = normal; grade 1 = suspicious changes; grade 2 = 
minimal abnormalities (small localized areas of erosion or sclerosis without 
alteration in the joint width); grade 3 = unequivocal abnormalities (moderate or 
advanced sacroiliitis with erosions, sclerosis, widening, narrowing or partial 
ankylosis) and grade 4 = total ankylosis. 
 
An analysis of a large group of patients with PsA was published by Gladman et al in 
1987 [20]. In a cohort of 220 patients assembled over an 11 year period, the 
prevalence of sacroiliitis was reportedly 27%. In a study conducted by Battistone et 
al [17] published in 1999, 221 patients with PsA were enrolled in a study over a 
period of 32 months. 202 radiographs were available for interpretation by a single 
experienced musculoskeletal radiologist who interpreted large batches over week- 
long sessions. These radiographs included multiple films from peripheral joints. 
They concluded a 78% prevalence of sacroiliitis in a large, multicentre cohort study 
of patients with PsA, a figure much higher than the previously reported 27% by 
Gladman et al [20]. Sacroiliac joint abnormalities are a minor feature of RA. 
 
PsA, reactive arthritis and ankylosing spondylitis are grouped in the category of 
seronegative spondyloarthritis. Differentiation between these disorders relies on the 












In PsA, as in reactive artrhitis, large comma shaped paravertebral ossifications may 
be seen at the thoracolumbar junction. Initially, ossification is thick and fluffy or thin 
and curvilinear on one side of the spine, paralleling the lateral surface of the 
vertebral bodies. Eventually it may produce a large and bulky outgrowth that merges 
with the underlying osseous and discal tissue. The greater size, asymmetric 
distribution and location farther away from the vertebral column help to distinguish 
paravertebral ossification from syndesmophytes of ankylosing spondylitis and 
spondylitis in inflammatory arthritis. Spondylitis is uncommon in the absence of 
sacroiliitis. The facet joints are relatively spared and there is absence of vertebral 
body “squaring” [1, 4]. A study by Helliwell and Porter [21] showed that new bone 
formation and erosion at major entheseal sites was most commonly observed in 
ankylosing spondylitis. Plain radiographic features of major enthesopathy are poor 
discriminators between PsA and RA. 
 
Cervical spine abnormalities include atlantoaxial subluxation, apophyseal joint space 
narrowing and sclerosis, osseous irregularity at the discovertebral joint and extensive 
proliferation along the anterior surface of the spine [14]. Anterior subluxation 
predominates, but lateral instability, as reported in RA, also occurs. Associated 
erosive and sclerotic abnormalities of the odontoid process are frequent in patients 
demonstrating atlantoaxial subluxation. Rarely, subaxial cervical instability with 
cord compression is evident in psoriatic spondylitis, resembling changes observed in 
RA [6]. 
 
Elsewhere in the axial skeleton, the manubriosternal, sternoclavicular, costovertebral 
joints, the symphysis pubis and the tendinous connections of the pelvis may 
demonstrate significant changes such as soft tissue swelling, subchondral erosions 
and synostosis. Abnormalities of the phalangeal tufts and calcaneus are 
characteristic. Retrocalcaneal burstis creates a radiodense area adjacent to the 
posterosuperior aspect of the bone. The Achilles tendon may be thickened. Poorly 












Significant joint destruction and deformity are more characteristic of PsA than of 
reactive arthritis. Furthermore, in PsA, both upper and lower extremities are 
involved, distinguishing it from reactive arthritis which predominantly involves the 
joints of the lower extremity. PsA can affect synovial and cartilaginous joints and 
sites of tendon and ligament attachment to bone in both the appendicular and the 
axial skeleton. In this respect it is similar to reactive arthritis and ankylosing 
spondylitis and differs from RA [6]. 
 
Ankylosing spondylitis affects mainly the axial skeleton. The spinal changes consist 
of thin, linear and symmetrically distributed outgrowths. Apophyseal joint 
involvement and osteitis with squaring of vertebral bodies are more frequent in 
ankylosing spondylitis than in reactive arthritis. Bilateral, symmetrical sacroiliac 
joint abnormalities are almost universal [6]. Spondylitis, a characteristic feature of 
PsA, may be difficult to distinguish radiologically from ankylosing spondylitis 
[11,14]. Syndesmophytes occur in both PsA and ankylosing spondylitis, but a 
distinguishing feature may be that in PsA the syndesmophytes are paramarginal and 
do not appear in consecutive vertebra [14]. 
 
Radiographic scoring methods 
Several scoring methods for psoriatic arthritis have been adapted from existing RA 
scoring systems [11]. These have been proposed for the assessment of structural 
damage in peripheral joints. The scoring methods by Larsen et al.  [22], Steinbrocker 
et al. [23] and Sharp et al. [24] are most commonly reported for evaluating 
radiographic changes and quantifying damage [25]. These have been validated for 
RA, but studies in PsA are lacking. Currently, no single method has achieved 
universal acceptance in the assessment of PsA. 
 
Steinbrocker‟s method [23] was devised in 1949 and is still widely used. Global 
changes are assessed, giving an overall measure of joint damage from 0 to 4. The 
severity of radiological involvement is scored by the degree of soft tissue swelling, 











performed rapidly and thus is useful in clinical practice. No radiographic standards 
are employed in using this method.  
Larsen‟s method [22] was introduced in 1977. Rau in 1995 [26] modified Larsen‟s 
method by quantifying the extent of joint space destruction required to attain stages 
2-5. Larsen, like Steinbrocker, assessed the joint globally. Scores range from 0 to 5 
depending on the extent of osteoporosis, joint space narrowing, erosions and joint 
destruction. This method is based on an atlas of standard radiographs in an attempt to 
improve reproducibility. Theoretically, Larsen‟s method may be more responsive for 
detecting change than Steinbrocker‟s method for any given joint as this index has an 
additional stage to detect change.  
Sharp‟s method [24] was developed in 1971 and modified in 1985 [27]. Erosions and 
joint space narrowing are scored separately in this method for a total of 35 
observations in each hand. This detailed analysis provides a greater sensitivity and 
amplitude to change than Larsen‟s and Steinbrocker‟s methods in patients with RA, 
but may not be as sensitive in detecting changes in PsA as compared to RA, since the 
erosions and new bone formation in PsA are often paramarginal or involve the shaft 
of the phalanges. These lesions would not be accounted for by Sharp‟s method, as it 
detects discrete intra articular erosions and joint space narrowing, unlike Larsen‟s 
and Steinbrocker‟s methods that score the joint globally.  
 
The Sharp-Van der Heijde modified scoring method for PsA [11] is a detailed 
scoring method evaluating erosions, joint space narrowing, subluxation, ankylosis, 
gross osteolysis and pencil in cup. In addition to the joints evaluated for RA, the DIP 
joints of the hands are assessed. This adapted method for PsA is being applied by 
two readers in two placebo controlled clinical trials evaluating efficacy of anti-TNF 
treatment in PsA. This data will give insight on intra reader and inter reader 
agreement, discrimination among patients with different disease status and sensitivity 
to change. From these trials it is hoped that one may deduce which joints yield the 
most information and how gross osteolysis and pencil in cup should be included in 












At the University of Toronto‟s PsA clinic, radiological progression in the peripheral 
joints of patients is assessed by a modification of the Steinbrocker technique [11,25]. 
The original Steinbrocker classification scored a patient according to their worst 
joint. The modified technique scores each joint on a 0–4 scale where: N 0 is normal, 
N 1 reflects juxta articular osteopaenia or soft tissue swelling, N 2 is the presence of 
erosion, N 3 is the presence of erosion and joint space narrowing, N 4 is total joint 
destruction, either lysis or ankylosis. This method reflects the biological changes in 
the arthritic joint, from soft tissue swelling to total joint destruction. 
 
In this method the Toronto group, led by Gladman, scored all the joints of the hands 
(with the wrist considered one joint), all metatarsophalangeal (MTP) joints and the 
IPJ of the big toe. This included a total of 28 joints in the hands and 12 joints in the 
feet, thus 40 joints altogether. The maximum score possible is 160, if all joints had a 
score of 4 [11]. 
Rahman and Gladman et al [25] conducted a study comparing the reliability and 
responsiveness of the original Steinbrocker‟s, the modified Steinbrocker‟s and 
Larsen‟s radiological scoring methods for detecting radiological change in PsA over 
time. Two sets of radiographs of the hands and feet, 2 years apart, were selected from 
68 patients. Films were randomly presented and scored independently by a 
rheumatologist and a radiologist, in a blinded fashion using all methods. They 
concluded that Larsen‟s and Steinbrocker‟s radiological scoring methods were 
reliable and reproducible. Larsen‟s and the modified Steinbrocker‟s methods were 
both equally responsive and superior to the original Steinbrocker‟s to detect 
radiographic change in PsA. Larsen‟s and the modified Steinbrocker‟s methods can 
be used to monitor disease progression, examine clinical correlations or study the 
effects of anti-rheumatic drugs in the radiographic assessment of PsA.  
 
The scoring method for PsA should consider both the destructive and proliferative 
changes. The Psoriatic Arthritis Ratingen Score (PARS) was developed in the early 
1990s, specifically for the radiographic assessment of patients with PsA. The method 
consisted of two separate scores namely the destruction score (DS) and the 











DIP joints, two IPJs of the thumbs, eight PIP joints, ten MCP joints, both wrists, both 
IPJs of the great toes and second to fifth MTP joints. All joints were scored 
separately for destruction and proliferation.  
The destruction score (DS) was based on the amount of joint surface destruction on a 
0–5 scale. Joint surface destruction was defined by the length of interruption of the 
cortical plate in relation to the total joint surface. The proliferation score (PS) 
considered any kind of bony proliferation typical for PsA on a 0–4 scale. The DS (0–
200) and the PS (0–160) were added to give the total score (TS) (0–360) for each 
patient.  
 
In summary, PsA has a wide clinical and radiological spectrum. In some patients, a 
single diagnosis of PsA on the basis of radiographic changes cannot be 
accomplished. Differentiation between the seronegative spondyloarthritides relies on 
the distribution of radiographic abnormalities and clinical information. The 
radiographic features of PsA can be grouped into destructive and proliferative 
changes, which may occur simultaneously. In this manner it can be differentiated 
from RA. The role of radiology in the assessment of patients with PsA is recognised, 
where the baseline radiographic changes could predict progression of structural 
damage. In the initial phase of PsA, radiographs may be entirely normal. However, 
conventional radiography remains an easy, cheap and accessible investigation, which 
allows the assessment of structural damage and is able to measure treatment efficacy.  
 
Against this background, this study describing the radiological features of PsA in 31 
patients with clinical features of PsA attending a specialist rheumatic diseases unit at 
















PATIENTS AND METHODS 
 
Study design 
A retrospective descriptive study. 
 
Aims 
    To describe the severity and joint distribution of radiological change of 
PsA in a population, examined in a specialist clinic, using the Psoriatic 
Arthritis Ratingen Score (PARS) to compute radiological severity.  
     To correlate the severity of the total radiographic score with the duration 
of disease, the number of disease modifying anti-rheumatic drugs 
(DMARDS) and the inflammatory marker, C- reactive protein (CRP).  
     To determine the prevalence, and describe the distribution, of sacroiliitis 
using the 5-point scale according to the Atlas of Standard Radiographs in 
Arthritis [19]. 
 
Study population and sampling 
48 sets of radiographs of the hands, feet, pelvis, lumbar and cervical spines were 
collected in 2003 as part of a study conducted for a large multicentre international 
study by the CASPAR (Classification criteria for Psoriatic Arthritis) study group.  
The study population consisted of 48 patients who attended the D6 Princess Alice 
Rheumatology Unit at Groote Schuur Hospital, Cape Town, with clinically 
confirmed PsA. The diagnosis was based upon the opinion of rheumatologists 
with expertise in PsA. The following history, clinical features and laboratory tests 
were considered:  
    A personal and/or family history of psoriasis was elicited from the patient, 
general practitioner, dermatologist or rheumatologist. Physical evidence 
of psoriasis was recorded. 
    13 clinical features were evaluated, including the presence of dactylitis or 











heel pain, clinical sacroiliitis, inflammatory neck, thoracic or lower back 
pain, subcutaneous nodules, iritis, systemic features of RA and the 
presence of clinical small joint ankylosis.  
    The distribution of the joints involved was recorded on a mannequin 
drawing.  
     Laboratory tests included RF and CRP.  
 





For the purposes of this study, the radiographs of the hands, feet and pelvis only 
were assessed. Antero-posterior projections were available for assessment of the 
hands and feet. The right and left sides were exposed on the same film. The 
sacroiliac joints were assessed on the available coned antero-posterior projections 
of the pelvis. The Psoriatic Arthritis Ratingen Score (PARS) was applied for the 
assessment of the bones and joints of the hands and feet. This method [12] only 











joints are not included in the scoring system. For the purposes of this study, the 
total score will be referred to as the total radiographic score (TRS). 
The TRS, for each patient, includes the 40 joints of the hands and feet namely eight 
DIP joints, eight PIP joints, the two IPJs of the thumbs, ten MCP joints, both wrists, 
both IPJs of the great toes and the second to fifth MTP joints. All joints were scored 
separately for destruction and proliferation.  
 
The TRS (0-360) is the sum of the total destruction score (TDS) (0-200) and the 
total proliferation score (TPS) (0-160). 
The destruction score of an individual joint was restricted to erosive damage and 
bone destruction. Grading was based on the amount of joint surface destruction. 
Joint surface destruction was defined by the length of the interruption of the 
cortical plate in relation to the total joint surface. The total joint surface was 
defined by the margins of the joint capsules attaching to the bones in the 
diarthrodical joints and as the complete circumference of the bones in the wrist.  
 
Every individual joint was graded on a 0-5 scale as follows: 
0 = normal 
1= one or more definite erosions with interruption of the cortical plate of >1mm 











2= one or more erosions with destruction of the joint surface of 11-25% 
3= 26-50% destruction of the joint surface 
4= 51-75% destruction of the joint surface 
5= total destruction of the joint surface (>75%) or bony ankylosis 
 
The total proliferation score sums up bony proliferation typical for PsA, 
including paraarticular spikes, supracortical bone formation, diaphyseal 
thickening and enlargement of the bone compared to the opposite side.  
 
Every individual joint was graded on a 0-4 scale as follows: 
0= normal 
1= bony proliferation of 1-2mm or bone growth up to 25% of the original size 
(diameter) 
2= bony proliferation of 2-3mm or bone growth of 26-50% of the original size  
3= bony proliferation of >3mm or bone growth of >50% of the original size  
4= bony ankylosis 
 
The 5-point grading scale, according to the Atlas of Standard Radiographs in 
Arthritis [17], was applied for the assessment of sacroiliitis. The score ranged 
from 0-4: Grade 0 = normal; grade 1 = suspicious changes; grade 2 = minimal 
abnormalities; grade 3 = unequivocal abnormalities and grade 4 = total ankylosis. 
 
Instruments 
The author, a qualified radiologist, visually scored the 31 radiographic film sets. 













A scoring sheet, developed from original publications [12,17], was used to score 
the radiographs. For the purposes of this study, the total destruction score is the 
sum of the total destruction scores on the right and the left and the total 
proliferation score is the sum of the total proliferation scores on the right and the 
left. See Appendix 1 (Data capture sheet). The score at each joint level i.e. DIP, 
PIP, MCP, IPJ of the thumb, wrist, IPJ of the great toe and MTP joints, was 
summed, for both the destructive and proliferative processes. 
 
The data was entered into a Microsoft Excel spreadsheet. The statistical software 
programme Statistica version 10 was used to analyse the data. Descriptive 
statistics (mean, median and standard deviations) and non-parametric Spearman 
rank correlation co-efficients were applied to interpret data. Variance was 
calculated as the square of rho (r
2
). P value < 0.05 was considered significant. 
The 95% confidence interval was calculated as 95% CI = estimate +/- 1.96 * SE 
(estimate). Multivariate analysis, which requires a larger sample size, was not 
possible. 
 
ETHICAL AND LEGAL CONSIDERATIONS 
This is a non-invasive retrospective study in patients receiving standard of care 
medication for PsA. The radiation exposure was delivered as part of the previous 
trial and is not considered to have detrimental effects. The original study received 
approval by the University of Cape Town‟s Health Sciences Research Ethics 
Committee (UCT HREC) in 2003. Our study received approval from the UCT 





















There were 14 (45%) males and 17 (55%) females, with an age range from 25 to 78 
years and a mean of 53 with a standard deviation (SD) = 13.4. There was a weak 
correlation between the TRS and age (r
2
 = 14%; p < 0.05). There were 29 (94%) 
coloured (mixed race), 2 (6%) white and 0 black patients.  
All Groups
Histogram of Sex

























Data in Analysis - 17Mar2011.stw 29v*31c
















































Figure 3: Race distribution  
 
Duration of psoriasis and psoriatic arthritis 
The duration of psoriasis ranged from 1 to 62 years with a mean duration of 14.5 
years and a SD = 13.2 This was as a result of one patient, aged 78 years, who 
developed psoriasis at age 16. The duration of PsA ranged from 3 months to 37 years 




K-S d=.16482, p> .20; Lil l iefors p<.05
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Histogram of Duration PsA
Data in Analysis - 17Mar2011.stw 29v*31c
















Figure 5: Duration of psoriatic arthritis (years) 
 
Disease modifying anti-rheumatic drugs (DMARDs) 
Seven (22.58%) patients were not receiving any DMARD treatment, 19 (61.29%) 
patients were treated with 1 DMARD, 4 (12.90%) with 2 DMARDs and 1 (3.23%) 
with 3 DMARDs. The mean number of drugs was 0.97 with a SD = 0.71. 
 
All Groups
Histogram of No. DMARDS
Data in Analysis - 17Mar2011.stw 29v*31c






























Total radiographic score distribution 
The TRS ranged between 7 and 123 with a mean of 30.7 and a SD = 23.9. There 
were no patients with a score of 0. Therefore, all patients assessed had radiographic 
change. 8 (25.81%) patients had a score between 7 and 20 with 3 (9.67%) patients 
scoring 7, the lowest score. Nineteen patients (61.29%) had a score between 20 and 
40, the highest score range. 1 (3.23%) patient scored between 20 and 40 and 2 
(6.45%) patients scored between 60 and 80. No patients scored between 80 and 120. 




K-S d=.26744, p<.05 ; Lil l iefors p<.01
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Total destruction and total proliferation scores 
Table 1. Mean and standard deviation (SD) for TDS 
 TDS Right TDS LEFT TDS 
Mean 26.5 13.6 13 
SD 19.2 10.4 9.5 
 
Table 2: Mean and standard deviation (SD) for TPS 
 TPS Right TPS Left TPS 
Mean 4.2 2.3 1.9 
SD 5.9 3.4 3.1 
 
12 (38.71%) of the 31 patients had a positive TDS only with no proliferative change 
and 19 (61.29%) of the 31 patients had both a positive destruction and proliferation 
score. There were no patients who had a positive proliferation score only, without 
coexistent destructive change. 
 
Correlation between the TDS and TPS 
There was no significant correlation between the total destruction and total 
proliferation scores on either the right or the left side (r
2
 = 12% and 4% respectively; 
P > 0.05). 
 
Radiographic distribution 
Destruction Score Distribution 
31(100%) patients had a positive destruction score on the right, while 30 (96.77%) 
had a positive destruction score on the left. The TRS correlated significantly with the 
TDS on the right (r
2
 = 74%) and left (r
2 =











Figure 8: Mean DS distribution 
 
In the hand, the mean destruction score decreased from the most distal joint to the 
more proximal joint.  
 
Table 3: Destruction score (DS) distribution for the right hand and foot 
Variable N Mean SD Range CI -95% CI 95% 
Right DIP 31 4.10 3.51 0-17 2.81 5.38 
Right PIP 31 2.74 2.46 0-11 1.84 3.65 
Right MCP 31 2.32 3.16 0-13 1.17 3.48 
IPJ right thumb 31 0.81 1.11 0-5 0.40 1.21 
Right wrist 31 0.68 1.05 0-5 0.29 1.06 
IPJ right great toe 31 0.87 1.45 0-5 0.34 1.40 















Table 4: Destruction score (DS) distribution for the left hand and foot 
Variable N Mean SD Range CI -95% CI 95% 
Left DIP 31 4.10 3.80 0-16 2.70 5.49 
Left PIP 31 2.42 1.88 0-7 1.73 3.11 
Left MCP 31 2.35 3.04 0-15 1.24 3.47 
IPJ left 
thumb 
31 0.52 0.85 0-3 0.20 0.83 
Left wrist 31 0.48 1.00 0-5 0.12 0.85 
IPJ left 
great toe 
31 0.77 1.09 0-4 0.38 1.17 

















Figure 10: Number of patients with bilateral or unilateral destructive change 
 
All patients had a positive destruction score on the right. On the left, all female 
patients had a positive destruction score and almost all male patients, with the 
exception of one.  
 
The correlation between the various joints in the right and left hand and foot was 
determined as follows (Correlations are significant at p <0.05):  
The right hand/wrist 
Table 5: Correlation between the TRS and the destruction score of the individual 
joints of the right hand/wrist 
 
Pair of Variables 
Valid - N Spearman - R t(N-2) p-value 
Total score & DS Right DIP 31 0.663697 4.77823 0.000047 
Total score & DS Right PIP 31 0.622093 4.27881 0.000187 
Total score & DS Right MCP 31 0.481091 2.95522 0.006147 
Total score & IP thumb DS RT 31 0.491999 3.04332 0.004934 












The variance in the TRS was explained to a greater extent by the variance in the right 
DIP joint destruction score (r
2 
= 43%), than by the variance in the destruction scores 
in the right PIP (r
2 
= 38%), the IPJ of the right thumb (r
2 
= 24%) or the right MCP 
joint (r
2 
= 23%), suggesting that the right DIP joint was most severely affected. There 
was no significant correlation between the TRS and the destruction score of the right 
wrist joint. 
 
Table 6: Correlation between the TDS on the right and the destruction score of the 
individual joints of the right hand/wrist 
 






DS Right & DS Right DIP 31 0.598076 4.01870 0.000380 
DS Right & DS Right PIP 31 0.683388 5.04093 0.000023 
DS Right & DS Right MCP 31 0.588631 3.92117 0.000495 
DS Right & IP thumb DS 
RT 
31 0.405504 2.38893 0.023624 
DS Right & right wrist DS 31 0.166654 0.91019 0.370226 
 
However, the variance in the TDS on the right was explained to a greater extent by a 
variance in the right PIP joint destruction score (r
2
 = 46%), than by the variance in 
the destruction scores of the right DIP (r
2 
= 36%), right MCP (r
2 
= 34%) or the IPJ of 
the right thumb (r
2 
= 16%). This confirms a predilection for the DIP joint, but shows 
that the PIP joint is also commonly affected. There was no significant correlation 
between the TDS on the right and the destruction score of the right wrist joint. 
 
The destruction score of the right PIP is explained to a greater extent by a variance in 
age of the patient (r
2 
= 14%) and that of the right MCP by a variance in duration of 
psoriasis (r
2 
= 14%); these were considered significant at a p value < 0.05. The 
destruction score of the right DIP joints was not significantly explained by a variance 














 The right foot 
Table 7: Correlation between the TRS and the destruction score of the individual 
joints of the right foot 
 
Pair of Variables 
Valid - N Spearman - R t(N-2) p-value 
Total score & IP great toe DS RT 31 0.433299 2.58906 0.014893 
Total score & right MTP DS 31 0.298792 1.68607 0.102514 
 
There was a significant correlation between the TRS and the destruction score of the 
IPJ of the right great toe (r
2
= 18%), but no significant correlation with the destruction 
score of the right MTP joints. 
 
Table 8: Correlation between the TDS on the right and the destruction score of the 
individual joints of the right foot 
 
Pair of Variables 
Valid - N Spearman - R t(N-2) p-value 
DS Right & RT MTP DS 31 0.481913 2.96179 0.006048 
DS Right & IP great toe DS RT 31 0.474754 2.90487 0.006962 
 
The variance in the TDS on the right was explained to a similar extent by the 
variance in the destruction scores of the right MTP joint (r
2
= 23%) and the IPJ of the 




 The left hand/wrist 
Table 9: Correlation between the TRS and the destruction score of the individual 
joints of the left hand/wrist 
 
Pair of Variables 
Valid - N Spearman - R t(N-2) p-value 
Total score & DS left DIP 31 0.516065 3.24452 0.002961 
Total score & DS left PIP 31 0.686632 5.08610 0.000020 
Total score & DS left MCP 31 0.588576 3.92060 0.000496 
Total score & IP thumb DS LT 31 0.211353 1.16448 0.253722 











The variance in the TRS was explained to a greater extent by the variance in the 
destruction score of the left PIP joint (r
2 
= 48%), than the variance in the destruction 
scores of the left MCP (r
2
 = 35%) or the left DIP joints (r
2 
= 26%). There was no 
significant correlation between the destruction scores of the IPJ of the left thumb, or 
the wrist joint, and the TRS. 
 
Table 10: Correlation between the TDS on the left and the destruction score of the 
individual joints of the left hand/wrist 
 
Pair of Variables 
Valid - 
N 
Spearman - R t(N-2) p-value 
DS Left & DS left DIP 31 0.575104 3.78572 0.000714 
DS Left & DS left PIP 31 0.623127 4.29044 0.000181 
DS Left & DS left MCP 31 0.643209 4.52374 0.000095 
DS Left & IP thumb DS 
LT 
31 0.229197 1.26802 0.214877 
DS Left & left wrist DS 31 0.373906 2.17101 0.038256 
 
The variance in the TDS on the left was explained to a greater extent by the variance 
in the destruction score of the left MCP joint (r
2 
= 41%), than the variance in the 
destruction scores of the left PIP (r
2
 = 38%), the left DIP (r
2 
= 33%) or the left wrist 
joints (r
2 
= 14%). There was no significant correlation with the IPJ of the left thumb.  
 
The destruction score of the left MCP joint is explained by a variance in both the age 
of the patient (r
2 
= 19%) and the duration of psoriasis (r
2 
= 24%), but not by a 
variance in the duration of PsA. The destruction score of the left PIP and DIP joints 

















The left foot 
Table 11: Correlation between the TRS and the destruction score of the individual 
joints of the left foot 
 
Pair of Variables 
Valid - N Spearman - R t(N-2) p-value 
Total score & IP great toe DS LT 31 0.332525 1.89875 0.067588 
Total score & left MTP DS 31 0.292501 1.64720 0.110311 
 
There was no significant correlation between the TRS and the destruction scores of 
the IPJ of the left great toe (r
2 
= 18%) or left MTP joints. 
 
Table 12: Correlation between the TDS on the left and the destruction score of the 
individual joints of the left foot 
 
Pair of Variables 
Valid - N Spearman - R t(N-2) p-value 
DS Left & IP great toe DS LT 31 0.386111 2.25407 0.031920 
DS Left & left MTP DS 31 0.384807 2.24513 0.032553 
 
There was, however, a significant correlation between the destruction scores of both 
the IPJ of the left great toe (r
2 
= 15%) and the left MTP joints (r
2 
= 14%) with the 
TDS on the left.  
 
Proliferation Score Distribution 
Of the 31 patients included in this study, 16 (51.61%) patients had a positive 
proliferation score on the right, while 17 (54.84%) patients had a positive 
proliferation score on the left, with a variation in the number of joints involved as 
well as the joint distribution. There was a slight female predominance (F = 52.9%; M 
= 50%) on the right and a slight male predominance (M = 64.29%; F= 47.06%) on 
the left. 
 
The correlation between the TPS, on the right and left, with the TRS (r
2
 = 30% and r
2
 
















Table 13: Proliferation score (PS) distribution for the right hand and foot 
Variable N Mean SD Range CI -95% CI 95% 
Right DIP 31 0.42 1.26 0-5 -0.04 0.88 
Right PIP 31 1.06 1.48 0-5 0.52 1.61 
Right MCP 31 0.19 0.40 0-1 0.05 0.34 
IPJ right thumb 31 0.13 0.43 0-2 -0.03 0.29 
Right wrist 31 0.16 0.90 0-5 -0.17 0.49 
IPJ right great toe 31 0.26 0.96 0-5 -0.10 0.61 















Table 14: Proliferation score (PS) distribution for the left hand and foot 
Variable N Mean SD Range CI -95% CI 95% 
Left DIP 31 0.10 0.40 0-2 -0.05 0.24 
Left PIP 31 0.94 1.18 0-3 0.50 1.37 
Left MCP 31 0.58 2.22 0-11 -0.23 1.39 
IPJ left thumb 31 0.10 0.30 0-1 -0.01 0.21 
Left wrist 31 0.16 0.90 0-5 -0.17 0.49 
IPJ left great toe 31 0.03 0.18 0-1 -0.03 0.10 


















Figure 13: Number of patients with bilateral or unilateral proliferative change 
 
The PIP joints demonstrated most bilateral proliferative change (35.48%) compared 
with only 3.23% bilateral DIP joint change. The MCP joints demonstrated most 
unilateral joint proliferative change, compared with only 16% unilateral DIP joint 
change. Figure 13 highlights the lack of proliferative changes in the different hand 
joints. 
 
The right hand/wrist 
Table 15: Correlation between the TRS and the proliferation score of the individual 
joints of the right hand/wrist 
 
Pair of Variables 
Valid - N Spearman - R t(N-2) p-value 
Total score & PS right DIP 31 0.440723 2.64400 0.013083 
Total score & PS right PIP 31 0.331772 1.89392 0.068250 
Total score & PS right MCP 31 0.150837 0.82168 0.417962 
Total score & IP thumb PS right 31 0.375505 2.18182 0.037372 












The variance in the TRS was explained to a greater extent by the variance in the 
proliferation score of the right DIP joint (r
2 
= 19%), than the variance in the 
proliferation score of the IPJ of the right thumb (r
2 
= 14%). There was no significant 
correlation between the TRS and the proliferation score in the right PIP, MCP or 
wrist joints. 
 
Table 16: Correlation between the TPS on the right and the proliferation score of the 
individual joints of the right hand/wrist 
 
Pair of Variables 
Valid - N Spearman - R t(N-2) p-value 
PS Right & PS right DIP 31 0.509752 3.19078 0.003398 
PS Right & PS right PIP 31 0.816265 7.60930 0.000000 
PS Right & PS right MCP 31 0.500288 3.11152 0.004155 
PS Right & IP thumb PS right 31 0.493769 3.05778 0.004758 
PS Right & right wrist PS 31 0.293246 1.65180 0.109365 
 
The variance in the TPS on the right was explained to a greater extent by the 
variance in the proliferation score of the right PIP joint (r
2 
= 67%), than the variance 
in the proliferation score of the right DIP (r
2 
= 26%), the right MCP (r
2 
= 25%) or the 
IPJ of the right thumb (r
2 
= 24%). The TPS on the right had a weak correlation with 
age (r
2
 = 13%), but not with the duration of PsA or duration of psoriasis (These were 
considered significant at a p value < 0.05). 
 
 The right foot 
Table 17: Correlation between the TRS and the proliferation score of the individual 
joints of the right foot 
 
Pair of Variables 
Valid - N Spearman - R t(N-2) p-value 
Total score & IP great toe PS RT 31 0.357459 2.06116 0.048355 












The variance in the TRS was explained to a greater extent by a variance in the 
proliferation score of the IPJ of the right great toe (r
2 
= 13%), but there was no 
significant correlation with the right MTP joint (r
2 
= 0.5%; P > 0.05). 
 
Table 18: Correlation between the TPS on the right and the proliferation score of the 
individual joints of the right foot 
 
Pair of Variables 
Valid - N Spearman - R t(N-2) p-value 
PS Right & IP great toe PS RT 31 0.527447 3.34325 0.002295 
PS Right & right MTP PS 31 0.206358 1.13572 0.265374 
 
The variance in the TPS on the right was explained by a variance in the proliferation 
score of the IPJ of the right great toe (r
2 
= 28%), but there was no significant 
correlation with the right MTP joint (r
2 
= 4%; P > 0.05). 
 
 The left hand/wrist 
Table 19: Correlation between the TRS and the proliferation score of the individual 
joints of the left hand/wrist 
 
Pair of Variables 
Valid - N Spearman - R t(N-2) p-value 
Total score & PS left DIP 31 0.150249 0.81840 0.419800 
Total score & PS left PIP 31 0.124114 0.67358 0.505909 
Total score & PS left MCP 31 0.216403 1.19365 0.242287 
Total score & IP thumb PS left 31 0.427560 2.54703 0.016431 
Total score & left wrist PS 31 0.306619 1.73475 0.093403 
 
The variance in the TRS was explained by a variance in the IPJ of the left thumb (r
2 
=18.5%). There was no significant correlation with the proliferation score of the left 













Table 20: Correlation between TPS on the left and the proliferation score of the 
individual joints of the left hand/wrist 
 
Pair of Variables 
Valid - N Spearman - R t(N-2) p-value 
PS left & PS left DIP 31 0.318692 1.81062 0.080572 
PS left & PS left PIP 31 0.730281 5.75672 0.000003 
PS left & PS left MCP 31 0.528702 3.35430 0.002230 
PS left & IP thumb PS left 31 0.205669 1.13175 0.267010 
PS left & left wrist PS 31 0.322640 1.83564 0.076686 
 
The variance in the TPS on the left was explained to a greater extent by the variance 
in the proliferation score of the left PIP joint (r
2 
= 53%) than the left MCP joint (r
2 
= 
28%). There was no significant correlation with the proliferation score of the left DIP 
joint, IPJ of the thumb or wrist joint. These findings suggest that proliferative 
changes are more prominent in the PIP and MCP joints of the hand, rather than the 
DIP joints, as might be expected.  
 
 The left foot 
Table 21: Correlation between the TRS and the proliferation score of the individual 
joints of the left foot  
 
Pair of Variables 
Valid - N Spearman - R t(N-2) p-value 
Total score & IP great toe PS LT 31 0.102206 0.55330 0.584302 
 
There was no significant correlation between the TRS and the proliferation score of 
the IPJ of the left great toe. The correlation between the TRS and the proliferation 
score of the left MTP joint was not possible as the proliferation score for the left 















Table 22: Correlation between TPS on the left and the proliferation score of the 
individual joints of the left foot 
 
Pair of Variables 
Valid - N Spearman - R t(N-2) p-value 
PS left & IP great toe PS LT 31 0.086037 0.46505 0.645369 
 
There was no significant correlation between the TPS on the left and the proliferation 
score of the IPJ of the left great toe. The correlation between the TPS on the left and 
the proliferation score of the left MTP joint was not possible as the proliferation 
score for the left MTP joints was 0.  
The TPS on the left had a significant correlation with the duration of psoriasis (r
2
 = 
29%) and age of patient (r
2



























Comparison of destructive and proliferative change in individual joints 
Table 23: Comparison of destructive and proliferative change in individual joints in 





No change Both destructive and 
proliferative change 
Right DIP 24(77.42%) 0 2 (6.45%) 5 (16.13%) 
Left DIP 29 (93.54%) 0 1 (3.23%) 1 (3.23%) 
Right PIP 13 (41.94%) 1 (3.23%) 5 (16.13%) 12 (38.71%) 
Left PIP 14 (45.16%) 2 (6.45%) 3 (9.68%) 12 (38.71%) 
Right MCP 17 (54.84%) 2 (6.45%) 8 (25.81%) 4 (12.90%) 
Left MCP 24 (77.42%) 2 (6.45%) 4 (12.90%) 1 (3.23%) 
IPJ right 
thumb 
14 (45.16%) 1 (3.23%) 14 (45.16%) 2 (6.45%) 
IPJ left 
thumb 
8 (25.81%) 0 20 (64.52%) 3 (9.68%) 
Right wrist 14 (45.16%) 0 16 (51.61%) 1(3.23%) 
Left wrist 11 (35.48%) 0 20 (64.52%) 0 
IPJ right 
great toe 
10 (32.26%) 0 18 (58.06%) 3 (9.68%) 
IPJ left 
great toe 
15 (48.39%) 0 15 (48.39%) 1 (3.23%) 
Right MTP 16 (51.61%) 0 14 (45.16%) 1 (3.23%) 
Left MTP 18 (58.06%) 0 13 (41.94%) 0 
 
Of the 31 patients with PsA reviewed in this study, a comparison of the presence of 
destructive and proliferative change in individual joints (Table 23) demonstrates that 
the majority of patients had destructive change occurring either as the only feature or 











DIP joint was most involved (93.54%), followed by the right DIP (77.4%) and left 
MCP joints (77.42%), demonstrating a predilection for the distal joints. The right PIP 
and left PIP joints demonstrated both destructive and proliferative change, each in 
38.71% of the patient population, compared to the right and left DIP and MCP joints. 
This demonstrates a predilection for proliferation at the proximal joints. Few patients 
had proliferative change as the only feature.  
 
Sacroiliac disease 
The prevalence of sacroiliac joint disease was 80.65%.  
In this study population, 5 patients (16.13%) had unilateral disease, 13 patients 
(41.94%) bilateral symmetrical disease, 7 patients (22.58%) bilateral asymmetrical 
disease and 6 patients (19.35%) had no sacroiliac involvement. The dominant pattern 
was a bilateral symmetrical disease. The mean grade of severity on the right was 1.39 
with a SD = 1.12 and on the left it was 1.32 with a SD = 1.14. 
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Figure 14: The distribution of radiographic grading of right-sided sacroiliac 
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Figure 15: The distribution of radiographic grading of left-sided sacroiliac joint 
disease, for 31 patients, is reflected in the histogram above. 
 
On the right side, 10 patients (32%) had grade 1 disease, 7 male (50%) and 3 female 
patients (18%). On the left side, 10 patients (32%) were also found to have grade 1 
disease; however the female subgroup predominated with 7 female (41%) and only 3 
male patients (21%).  
 
 Table 24: Comparison of sacroiliac joint (SIJ) disease in the right sacroiliac joints in 
both males and females 
Right SIJ Grade 0 Grade 1 Grade 2 Grade 3 Grade 4 
Male 3(21%) 7(50%) 3(21%) 1(7%) 0 














Table 25: Comparison of sacroiliac joint (SIJ) disease in the left sacroiliac joints in 
both males and females 
Left SIJ Grade 0 Grade 1 Grade 2 Grade 3 Grade 4 
Male 4(29%) 3(21%) 4(29%) 3(21%) 0 
Female 5(29%) 7 (41%) 1(6%) 4 (24%) 0 
 
On the right, grade 1 disease predominated in the male group (50%) and grade 3 
disease in the female group (35%), whereas on the left, grade 2 disease predominated 
in the male group (29%) and grade 1 disease (41%) in the female group. Grade 1 
disease, therefore was the most predominant bilaterally. There were no patients with 
grade 4 sacroiliac joint disease. The percentage of patients with Grade 2+ disease on 
the right = 42% and on the left = 39%. Prevalence of grade 2+ disease = 51.61%. 
19.35% of patients had grade 2 disease and 32.26% grade 3. There was no 
correlation between sacroiliac disease and the TRS, TDS or TPS. 
 
Correlation between the TRS and CRP, duration of PsA, the number of 
DMARDs and the severity of SIJ disease 
There was a weak correlation between the TRS and CRP (r
2
 = 16%; p value <0.035), 
but no significant correlation between the TRS and duration of PsA, the number of 
DMARDs or the severity of SIJ disease. In addition, there was no correlation 














Scatterplot of CRP against Total score














Figure 16: Correlation between CRP and the TRS (r
2



























Psoriatic arthritis (PsA) is a chronic, progressive disease [28,29,30]. The 
radiographic features of PsA have been grouped into destructive and proliferative 
changes. It is a diagnostic challenge to differentiate PsA from RA and the literature 
reports [6,10] indicate that the joint distribution and the simultaneous occurrence of 
destructive and proliferative change is a radiological distinguishing factor.  
 
Bone proliferation is a striking feature of PsA [12]. Juxta articular new bone 
formation was reported by the CASPAR Study Group [8] as the only radiographic 
feature significantly and independently associated with PsA. There was no 
description of the joint distribution.  
 
Radiographs reflect the progression or regression of the disease-related destructive or 
proliferative processes, but to be applied in clinical practice, it is necessary to 
quantify the radiographic change. The Psoriatic Arthritis Ratingen Score (PARS) 
was specifically developed as a method for scoring radiographic change in PsA. This 
method reliably quantifies the progression of the disease observed on radiographs 
and assesses both the destructive and proliferative processes of the disease. It is the 
only method to include both processes recognised in PsA [11,12,31]. 
 
Wassenberg et al [12] showed that there was good inter-observer variability 
regarding both the destruction score and the TRS. The reproducibility of the total 
proliferation score was less impressive for the two observers evaluating the 
radiographs in their study.  
 
The results of our study demonstrate that destructive change was detected by the 
radiologist in all patients, with all patients having destructive change on the right and 
96.77% on the left. There was a significant correlation between the TRS and the TDS 











Although there was a significant correlation between the TRS and the TPS on the 
right and left, fewer patients were found to demonstrate proliferative change, with 
less involvement of the individual joints when compared to those demonstrating 
destructive change (Figures 9 and 12). The variance in the TRS was explained to a 
greater extent by a variance in the TDS on the right and left. However, as stated by 
Wassenberg et al [12], intra and inter observer variability does exist and may be a 
confounding factor. 
 
Wassenberg [12] reported that when both the change in destruction and the change in 
proliferation were plotted against each other, there was no convincing correlation. 
This indicated that proliferation develops independently from destruction and vice 
versa [11,12]. Significant information is derived from measuring both processes 
separately. Although there was no correlation, both changes nearly always displayed 
a similar trend.       
  
The results of our study confirmed the above observation, as there was no correlation 




PsA develops in persons aged 35 to 55 years old. Punzi et al [32] noted that the 2-
year radiological outcome was worse in patients who were older than 60 years at 
disease onset. This outcome may be influenced by immune changes associated with 
aging, as suggested by the higher concentrations of IL1 beta and IL6 found in the 
synovial fluid of elderly onset psoriatic arthritis (EOPsA) patients. [28,32]. McHugh 
et al [33], did not support these findings in their study. They found the rate of 
progression to be similar across age groups, but admitted that the number of patients 
in their older age of onset group was small. 
The results of our study showed an age range from 27 to 78 years and a mean of 53 











patient, suggesting that there was a trend towards more severe disease in the older 
patient. 
 
Total radiographic score and duration of disease 
A prospective study by Kane et al [28] showed that PsA is a chronic disease with 
significant functional impairment and radiological damage at an early stage in the 
course of the disease. The results of our study demonstrated no correlation between 
TRS and duration of disease. There was however a significant, albeit weak, 
correlation between the destruction scores of the right and left MCP joints with 
duration of psoriasis (r
2 
= 14% and 24% respectively). This may suggest that 
subclinical joint damage occurs with the onset of the psoriasis a d precedes clinical 
symptoms of joint inflammation. 
 
Race predilection 
Kerr et al [34] reported that PsA in African Americans was one third less prevalent 
than in Caucasians. In a recent study by Tey et al [35] it was reported that Indian 
psoriatic patients were more likely t  have PsA compared to the other races. Mody et 
al [36] examined the clinical pattern of PSA in the Indian population attending the 
arthritis clinic, in Durban South Africa, over a period of 5 years and compared it with 
other western communities. They concluded that oligo-arthritis was the most 
common pattern, but was noted less often in Indians than in other race groups. The 
absence of black persons with PsA in the Groote Schuur hospital patient population 
compares with the literature reports [37] that PsA is rare amongst the indigenous 
black people of sub-Saharan Africa. There were, however, predominantly mixed race 
patients, consistent with the demographics in the Western Cape, South Africa. 
 
Inflammatory marker, C- reactive protein (CRP) 
Laboratory diagnostic markers are lacking in PsA and as a result, markers such as RF 
and the more specific anti-CCP (antibodies to cyclic citrullinated peptides) are used 
to differentiate RA from PsA [38]. Punzi and colleagues [38] also reported that the 











half of the patients with PsA. Gladman et al [2] analysed the data from the 
Adalimumab Effectiveness in PsA Trial (ADEPT). Their study demonstrated that 
baseline CRP was the dominant independent predictor of radiographic progression. 
The results of our study indicate that the inflammatory marker, CRP, weakly 
influences the severity of the disease.  
 
Disease modifying anti-rheumatic drugs (DMARDs) 
The modified Steinbroker scoring method has been used in case studies of several 
drugs in PsA, demonstrating that traditional DMARDs have not been able to prevent 
progression of joint damage in PsA [11]. 
 
Treatment options for peripheral disease, enthesitis and dactylitis, include non- 
steroidal anti-inflammatory drugs (NSAIDs), disease modifying anti-rheumatic drugs 
(DMARDs), local steroids and tumour necrosis factor (TNF) blocking agents. 
NSAIDs can control mild disease. Patients with progressive articular disease, not 
responsive to NSAIDs, should be treated with DMARDs to prevent joint damage and 
disability.  
In 2003 Pipitone et al [29] reviewed the literature to determine current concepts and 
new developments in PsA. Methotrexate and sulphasalazine were considered the 
DMARDs of choice, but the evidence for the use of methotrexate in PsA was largely 
empirical, while the clinical benefit induced by sulphasalazine appeared to be 
modest. Other DMARDs proposed for the treatment of PsA included cyclosporin, 
gold salts and leflunomide. However, none of the DMARDs available to date are 
effective in the treatment of psoriatic spondylitis. In addition, a number of patients 
with severe peripheral arthritis fail to respond to standard DMARDs. Despite clinical 
improvement with current DMARD treatment, PsA results in radiological damage in 
up to 47% of patients at a median interval of 2 years. [29]  
 
Recently De Vlam et al [30] in 2009 reported a major clinical response in 
approximately 30% of patients with methotrexate or leflunomide, but with no 











treat/number needed to harm ratio of all DMARDs in PsA and is able to induce 
clinical remission in at least 30% of patients [30]. TNF-blocking agents have also 
been demonstrated to slow down or halt radiographic progression. 
This study population, despite having been selected from a specialist clinic, is shown 
to have apparently mild disease as reflected by the total score, which ranged between 
7 and 123. However, the severity of PsA was not influenced by the number of 
DMARDs, as there was no correlation between the TRS and the number of 
DMARDs. This discrepancy may be due to the fact that some patients presented at 
relatively advanced stages of the disease (i.e. damage more than clinical activity). 
Most patients (61.29%) were treated with only 1 drug and there was no information 
regarding the time into the disease that the DMARD therapy was initiated. It is 
expected that the likelihood of the DMARD impacting on progression would be less 
in those patients with longer disease duration at the time of initiating DMARD 
therapy. 
 
Distribution of the involved joints 
McHugh et al [33] stated that more precise information was required on the rate and 
pattern of joint damage in view of the advent of biological therapies that offer 
potential for preventing disease progression. They measured clinical and radiological 
joint involvement rather than joint damage. Joint involvement was defined as the 
presence of either synovial swelling or joint deformity or radiological abnormality 
not solely attributable to osteoarthritis. The peripheral joint score ranged from 0-70, 
with one point for each involved joint. The rate of progression of joint score was 
calculated. The rate of progression was 0.4 peripheral joints per year and was similar 
across age groups at onset. They concluded that although a disproportionately high 
number of peripheral joints are involved in the first 12 months following disease 
onset, there continues to be a steady progression of peripheral joint involvement in 
patients with PsA. They did not assess destructive and proliferative change 















An early study by Meaney and Hayes in 1957 [4], assessing the radiographs of 4 
patients with PsA, reported destructive change in the DIP joints without associated 
involvement of the proximal joints or, at most, minimal involvement. 
Recent studies [6,12] describe the most typical sites as the IPJs of the hand and foot, 
the MCP and MTP joints, the calcaneus, the sacroiliac joint and the spine. Resnick 
[6] reported that the destructive arthritis of the DIP joints of the hands is the most 
known manifestation of the disease and that adjacent PIP joints frequently are 
affected with severe abnormalities encountered at the thumb, with relative sparing of 
the MCP joints.   
Our study clearly demonstrates involvement of the DIP, PIP and MCP joints by 
destructive change with the DIP being more involved than the PIP or MCP joints 
(Figure 9), although it also demonstrates that the PIP joints on the right and the MCP 
joints on the left contributed significantly to the destruction score (r
2 
= 46% and r
2
 = 
41% respectively). This implies that although the DIP joints are most involved by the 
destructive process, they are not the only joints involved. 
 
Our study also demonstrates that the joint most commonly involved by proliferative 
change is the PIP joint (Figure 12). The PIP joints on the right and left contributed 
significantly to the TPS on the right and left (r
2  
= 67% and r
2 
= 53% respectively).  
This implies that proliferative changes occurred predominantly in the PIP joints. 
 
In the right thumb, variance in the TRS was explained to a greater extent by a 
variance in the destruction score than the proliferation score (r
2  
= 24% vs r
2 
=14%) 
i.e. destructive change contributed more to total structural abnormalities than 
proliferative change and was the dominant process. Further assessment between the 
TDS on the right and the destruction score of the IPJ of the right thumb revealed a 
weak correlation (r
2 
=16%). This implies, that although destructive change was the 
more dominant process, the changes were mild. This is contrary to the results from 












In the left thumb, the variance in the TRS was explained by a variance in the 
proliferation score (r
2 
= 19%). However, there was no significant correlation with the 
destructive change at this joint i.e. proliferative change contributed more 
significantly to total structural abnormalities than the destructive change. This is the 
opposite of the findings in the contralateral IPJ of the thumb. Further assessment 
between the TPS on the left and the proliferation score of the IPJ of the left thumb 
revealed no significant correlation. Rather, a variance in the TPS on the left was 
explained to a greater extent by a variance in the proliferation score of the left PIP 
and left MCP joints (r
2 
= 53% and r
2 
= 28% respectively). This implies that 
proliferative changes are more common at the PIP and MCP joints than at the IPJ of 
the left thumb and DIP joints. 
Van der Heijde et al [12] reported that several patterns of distribution had been 
described, which included involvement of the distal and proximal IPJs which may 
occur in a ray pattern, involving all the joints of one digit as opposed to all the joints 
at the same level in both hands, as tends to occur in RA. 
 
Wright [13] reviewed 157 patients with psoriasis and various rheumatic complaints. 
In only one patient with PsA was arthritis limited to the distal joints, as was the 
finding in our study. Therefore, the separation of a subgroup of pure DIP joint 
disease is superfluous. 
 
Wrists 
Ory et al [14] reported that asymmetrical erosions might be visible radiographically 
in the carpus. In our study, the wrists demonstrated slightly asymmetrical destructive 
change, with bilateral destructive change in 8 (25.81%) patients and 9 (29.03%) 
patients with unilateral change. There was no proliferative change except in one 
patient. There was no significant correlation with the total radiographic, total 
destruction or total proliferation scores on the right or left. This highlights that the 














Resnick [6] reported that the forefoot is commonly affected with bilateral, 
asymmetrical destructive and proliferative changes predominating in the IP and MTP 
joints. The researchers do not quantify these changes. Reportedly, extensive 
destruction of the IPJ of the great toe is more characteristic of this disorder than any 
other disease [6]. Furthermore, Ory et al [14] also reported that erosive change and 
bone proliferation usually involve the IP and MTP joints; the IPJ of the great toe is 
most often affected.  
 
In our study, 20 (64.52%) patients had destructive change of the IPJ of the great toe, 
9 (29.03%) with bilateral change and 11 (35.48%) patients with unilateral change. 
There was a weak correlation between the destruction score of the IPJ of the right 
great toe with both the TRS (r
2 
= 18%) and the TDS (r
2 
= 22%) on the right and a 
weak correlation of the left great toe with the TDS (r
2 
= 15%) on the left, indicating 
that although these findings were significant, the changes did not contribute greatly 
to the overall structural abnormalities. 4 (12.9%) patients had unilateral proliferative 
change at this joint, 3 on the right side and 1 on the left, occurring in combination 
with destructive change. Once again, these changes were significant, but did not 
contribute greatly to the overall structural abnormalities. 
 
The changes in the MTP joints observed in our study were as follows: 13 (41.9%) 
patients had bilateral destructive change and 8 (25.81%) had unilateral destructive 
change. There was a significant correlation between the total destruction score on the 
right (r
2 
= 23%) and the left (r
2 
= 14%), but no significant correlation with the TRS 
on either side. Therefore, although the MTP joints are involved, the change 
contributes little to the TRS. 
There was only one patient with proliferative change involving the MTP joint. The 
changes affected the right MTP and occurred in combination with destructive 













Sacroiliac joint involvement 
There has been great controversy in the literature regarding the prevalence of 
sacroiliitis in patients with PsA. Two large studies conducted in 1987, by Gladman et 
al (20), and 1999 by Battisone et al (17) reported a prevalence of 27% and 78% 
respectively.  
Resnick et al [6], in 1989, reported that approximately 30-50% of individuals with 
PsA will develop sacroiliac disease and that bilateral abnormalities are more frequent 
with symmetrical abnormalities predominating. They also reported that although 
significant joint space narrowing and ankylosis can occur, the frequency of these 
findings, particularly ankylosis, is less than that observed in ankylosing spondylitis 
or the spondylitis associated with inflammatory bowel disease. 
 
In our study, the prevalence of sacroiliac joint disease was 80.65% with grade 1 
disease predominating. In 41.94% of patients it was observed to be bilateral and 
symmetrical. Only 16.13% of the patients in our study had unilateral disease. This 
high prevalence is as a result of including grade 1 disease, however when only grade 
2+ disease is considered, the prevalence decreases to 51.61%. This is lower than the 
78% obtained by Battisone et al [17] in 1999. 
 
We found 19.35% of patients with grade 2 disease and 32.26% with grade 3. When 
comparing these results with those of Battisone et al [17]  (grade 2 = 22.2% and 
grade 3+ = 55%), it is clear that our population had less advanced disease. 
 
Strengths and limitations 
The strength of the sample population was that it was selected from a specialist 
rheumatic diseases unit and each patient was assessed to have PsA based on the 
assessment of a qualified rheumatologist, which included a clinical and laboratory 
evaluation. The author of this study, a qualified radiologist trained to detect minor 












This study was a retrospective review of a small population, which was selected 8 
years previously, as part of a large international study. The hospital does not have a 
PACS (Picture Archiving and Communication System). The study was therefore 
limited by an incomplete archive in which only 31 of the original 48 film sets were 
obtained and included in this study. A larger population may reveal different results. 
The sacroiliac joints were assessed on antero-posterior projections of the pelvis 
rather than dedicated sacroiliac joint views. The ability of the radiologist, trained in 
the assessment of radiographs, to detect mild sacroiliac joint disease may be the 
reason for the high prevalence of sacroiliitis. When considering only Grade 2+ 
disease, the prevalence of sacroiliac disease decreases. A further limitation of this 
study was that one radiologist interpreted the radiographs and that there were no 
controls.  
 
Furthermore, there was inadequate laboratory data such as the lack of CRP blood 
levels in 5 of the 31 patients. No comment on the pattern of use or “handedness” was 


























The diagnosis of PsA is primarily based on clinical findings and laboratory tests. In 
certain cases it is difficult to differentiate between PsA, RA and other chronic 
inflammatory joint diseases. Conventional radiography may be normal in patients 
with early PsA. 
 
Magnetic resonance imaging (MRI) has reportedly enabled detection of bone marrow 
oedema and active synovitis visually, long before changes are detectable on 
conventional radiographs [39,40]. MRI features of PsA include synovitis, 
tenosynovitis, dactylitis, erosions, bone oedema and enthesitis. In a study conducted 
by Schoellnast et al [39], patients with PsA (n=18) and RA (n=21) underwent 
gadolinium-enhanced MRI of the wrist and hand. Periosteal enhancement, as a sign 
of periostitis, was significantly more frequent in patients with PsA than in patients 
with RA.  
 
A recent study [40] investigating the role of dynamic contrast-enhanced MRI in the 
differential diagnosis of PsA and RA, in the hand and wrist, showed that it was 
possible to differentiate between PsA and RA on the basis of synovial late 
enhancement after fifteen minutes.  
 
Histopathological differences could account for the significant difference in late 
contrast enhancement. Gadopentetate dimeglumine, which is transported in the 
plasma as an unlinked molecule and diffuses freely to the extracellular space, 
accounts for the signal increase in T1-weighted images. It is possible that the volume 
of the extravascular–extracellular space is wider in RA because of the higher 
cellularity and the multiple synovial layers of the highly inflammed synovium, 
leading to a slower washout of contrast medium. In contrast, in PsA, the inflammed 
synovium shows less cellularity and hyperplasia, thereby exhibiting a faster washout 












MRI images demonstrate widespread abnormalities in digits of people with PsA. 
Healy et al [12] showed circumferential soft tissue oedema in the majority of the 17 
patients included in their study. Although tender dactylitic digits had more 
abnormalities than other digits, a strong relationship between clinical and MRI scores 
was not demonstrated in their study.  
 
A new OMERACT (Outcome Measures in Rheumatoid Arthritis Clinical Trials) 
PsA MRI scoring system (PsAMRIS) for scoring inflammation and damage in PsA 
fingers was developed and preliminary validation was conducted [41,42].  In a cross-
sectional study, the interobserver reliability of the scores for synovitis, tenosynovitis, 
bone edema, bone erosions and bone proliferation revealed moderate to high 
reliability. However, reliability for periarticular inflammation as poor.  
In the longitudinal exercise, similar results were obtained for the status scores. 
However, while the change scores were moderately reliable for synovitis, 
tenosynovitis, periarticular inflammation and bone erosion, they were low or 
unmeasurable for bone edema and bone proliferation. At the DIP joints, reliability 
for change scores was acceptable only for synovitis and tenosynovitis. Overall 
PsAMRIS is a reliable instrument to assess PsA fingers. However, characteristic 
features of PsA, such as DIP joint involvement, periarticular inflammation, bone 
proliferation and bone edema were not reliably scored. Further refinement and 
validation of PsAMRIS is required before it may be used widely as a PsA specific 
instrument. 
 
Conventional radiography in the initial evaluation of sacroiliac joints disease is often 
insensitive for demonstrating the early changes of sacroiliitis [43]. MRI has been 
proposed as an imaging method to detect sacroiliitis earlier. Puhakka et al [44] 
published a MRI scoring system for the sacroiliac joints in early spondylarthropathy 
and in a separate study [45] compared it with clinical and laboratory parameters. The 
conclusion was that MRI is able to detect sacroiliitis defined as destructive or 















Our advice to future researchers conducting future studies, involving the evaluation 
of analogue films, is to convert the films into a digital format. This will allow the 
researcher to adjust the contrast and magnify the images, thus allowing for improved 
visualisation of any abnormalities, particularly the more subtle changes. A future 
study comparing the various scoring methods with a control group would be of 
interest. 
 
Further studies are needed to: 
 Improve the capacity of MRI to detect and score lesions as there is not yet an 
established, widely accepted method for the evaluation and quantification of 
MRI abnormalities. 

























 We measured radiological joint involvement and severity of joint damage, 
considering both the destructive and proliferative change. 
 This study population was shown to have mild disease as reflected by the 
TRS, which ranged between 7 and 123.  
 The results clearly demonstrate that destructive and proliferative changes are 
not present simultaneously in all patients.  
 The results also demonstrate that destructive change is the dominant process 
and that although the DIP joints are most involved by the destructive process, 
they are not the only joints involved. There is a degree of asymmetrical 
distribution in the hands. 
 The small joints of the hand are more severely affected by the destructive 
process than the joints of the toes. Howev r, the destructive changes in the 
toes have a greater degree of symmetry than the hand joints. 
 There were minimal structural changes at the wrist joint. 
 Proliferative change has been shown to predominantly involve the PIP joints, 
with the wrist, the IPJs of the thumb and great toe and the MTP joints least 
affected. 
 There was a weak correlation between the TRS and CRP, suggesting that the 
TRS is weakly influenced by CRP. 
 There was also a weak correlation between the TRS and age, suggesting a 
trend towards more severe disease in older patients. 
 There was no significant correlation between the TRS and the duration of 
PsA, the number of DMARDs or the severity of sacroiliac disease.  
 In addition, there was no correlation between the severity of sacroiliac 
disease and the total destruction or total proliferation scores.  
 Sacroiliac joint disease in this population was predominantly bilateral and 














IMAGES OF REPRESENATIVE CASES 
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Figure 17: The destruction score (DS) for the right DIP joints = 10 and left DIP 
joints = 11. The proliferation score (PS) for the right DIP joints = 5 and left DIP 
joints = 0. The DS for the right PIP joints = 12 and left PIP joints = 7; whereas 
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Figure 18: The greatest destructive change involves the interphalangeal joint of 
the right great toe (destruction score = 5) with moderate proliferative change 
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Figure 19: This patient had the highest total radiographic score. The PIP and 
MCP joints were more severely affected by destructive change than the DIP 
joints: Right DS DIP = 4; right DS PIP = 11; right MCP= 13. Left DS DIP =5; 
Left DS PIP = 5; left DS MCP = 15. Minimal proliferative change. Note the 
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 MTP joints 
bilaterally (RT DS = 16; LT DS = 12) with no proliferative change. Destructive 
change involvi g the interphalangeal joints of the great toe bilaterally, left more 
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Figure 21: Minimal destructive change – right 4
th
 DIP joint, right 2
nd
 PIP joints, 






 DIP joints, 3
rd
 PIP joint and right wrist (each 
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Figure 22: Minimal destructive change (score =1) in left 5
th
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Figure 23: Destructive changes involving predominantly the distal 
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Figure 24: Ankylosis of the interphalangeal joint of the right great toe; 
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APPENDIX 1: DATA CAPTURE SHEET 
 
Patient name:   
Folder number: 
Patient ID:  
Date of Xrays:    
Sex:  
Age:  
Duration of psoriatic skin disease: ________   
Duration of PsA: _______ 




 RIGHT LEFT TOTAL 
Total Destruction Score TDS 
(0-200) 
TDS RIGHT TDS LEFT TDS RIGHT + 
TDS LEFT  
Total Proliferation Score TPS 
(0-160) 
TPS RIGHT TPS LEFT TPS RIGHT+ 
TPS LEFT 
Total Radiographic Score 
(TDS +TPS) 




GRADING SCALE FOR SACROILIAC DISEASE: 
GRADE RIGHT LEFT 












Joint (RIGHT) Joint Number Destruction Score Proliferation Sc 
DIP 2nd   
 3rd   
 4th   
 5th   
IP of thumb    
PIP 1
st
   
 2
nd
   
 3
rd
   
 4
th
   
MCP 1
st
   
 2
nd
   
 3
rd
   
 4
th
   
 5th   
Wrist    
IP of great toe    
MTP 2nd   
 3rd   
 4
th
   
 5th   















Joint (LEFT) Joint Number Destruction Score Proliferation Sc 
DIP 2nd   
 3rd   
 4th   
 5th   
IP of thumb    
PIP 1
st
   
 2
nd
   
 3
rd
   
 4
th
   
MCP 1
st
   
 2
nd
   
 3
rd
   
 4
th
   
 5th   
Wrist    
IP of great toe    
MTP 2nd   
 3rd   
 4
th
   
 5th   
TOTAL     
 
 
